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viral lesion into squamous cell carcinoma of
the tongue in the HIV population: Case reports
and review of literatureKishore Shetty *, Janet LeighLSU Health Sciences Center, Oral and Maxillofacial Surgery, 1100 Florida Avenue,
#127, New Orleans, LA 70119, United StatesReceived 14 June 2005; accepted 15 June 2005Summary Human papilloma virus (HPV) is the most common sexually transmitted
viral disease responsible for mucosal warts and anogenital malignancies. HPV-asso-
ciated oral lesions include condyloma, focal epithelial hyperplasia and some squa-
mous cell carcinomas. Both oral and genital lesions caused by HPV are more
commonly seen in those co-infected with HIV. While there is some degree of HPV
genotypespecific clinical presentation, unusual manifestations of oral HPV disease
in the HIV-positive patient frequently occur. Examinations of oral-wart biopsy spec-
imens from HIV-positive individuals reveal a range of HPV genotypes, including cuta-
neous type 2; genital types 6, 11, 16 and 18; and oral type 13. However, the most
common HPV genotypes identified in HIV-associated oral warts are oral specific
HIV type 32 and the cutaneous HPV type 7. This paper presents two cases of HPV
lesions associated with these types, which progressed into oral squamous cell carci-
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leads to progressive immune suppression with
selective depletion of CD4+ T lymphocytes.
Numerous opportunistic infections occur second-
ary to this decrease in systemic immunity, parti-
cularly in the oral cavity with over 50% of
HIV-infected individuals developing oral patho-
logy.2 One pathogen that is commonly found in
both the oral and genital tracts of HIV-positiveved.
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rus (HPV); however, HPV infection can occur with
or without mucosal pathology.3,4 HPV-associated
oral lesions include condyloma, focal epithelial
and some squamous cell carcinomas.4,5 Both oral
and genital lesions caused by HPV are more com-
monly seen in those co-infected with HIV.6–8 Sys-
temic immune reconstitution for the HIV-positive
patient has been accomplished with highly active
anti-retroviral therapy (HAART), leading to de-
creases in systemic and oral infections, including
regression in HPV-induced cervical lesions.9,10 Par-
adoxically, recent reports have noted increases in
oral pathology consistent with HPV infection in
the presence of HAART.11–13 Although the major-
ity of the oral papillomas occur on the labial mu-
cosa, they can also occur on the buccal mucosa,
the tongue, the soft palate, and the gingiva. The
histopathology of oral warts almost invariably
demonstrates poorly differentiated, large, vacuo-
lated koilocytic cells, but the gross appearance
varies greatly.
A wide range of HPV genotypes in the HIV popu-
lation has been identified and categorized by site
of infection: cutaneous (2, 7), oral (13, 32) and
anogenital (6/11, 16) genotypes.14 However, the
most common HPV genotypes identified in HIV-
associated oral warts are oral — specific HIV type
32 and the cutaneous HPV type 7. This paper
presents two cases of HPV lesions associated with
type 32, which progressed to squamous cell
carcinoma.HPV DNA detection process
DNA extraction was performed using a multiplex
PCR reaction containing HPV L1-consensus primers
(PGMY09/11) and b-globin primers (GH20/PC04)
(supplied by: Roche Molecular Systems) to test
for sample adequacy (Fig. 1). Quality assurance
and contamination avoidance was performed by
using separate areas for DNA extraction, PCR
set-up and gel electrophoresis. For each PCR
run, a master PCR mix was prepared, and water
blanks were inserted after every fourth sample.
After amplification, products were analyzed by
electrophoresis, and the size of the band obtained
was compared with the molecular weight stan-
dard. DNA extracted from cultured SiHa cells
was used as a HPV+ positive control. PCR products
after 40 amplifications were considered positive
for HPV, if the products demonstrated the 254
base-pair b-globin band and the 450 base-pair
HPV band.Case #1A 43-years old Caucasian male presented to the
dental clinic at the Medical Center of New Orleans,
Louisiana, with an indurated mass on the tongue.
The mass slowly increased in size over a 5-month
period in the left anterior region of the tongue.
The patient’s medical history was significant for
HIV, manic depression, cholecystectomy, and neu-
rosyphilis. The CD4 count was 120 and the viral load
was 28 000. The patient was presently on a regimen
of Highly active Antiretroviral therapy: nevirapine
(Viramune; Boehringer Ingelheim Corporation,
Connecticut, USA), ritonavir (Kaletra; Abbott Labo-
ratories, Illinois, USA) and abacavir (Ziagen; Glaxo-
smithkline, Munich, Germany). There was no
history of smoking, drug abuse or family history
of cancer.
Reviewof systemswas unremarkablewith no otal-
gia, dysphagia, odynophagia, hoarseness, or cough-
ing. His physical examination was unremarkable
except for a 2 · 3 cm ulcerative, indurated, mass in
the left anterior tongue (Fig. 2). Cranial nerves II–
XII were intact with no paresthesia. There was no
fixation of tongue, lymphadenopathy or uvula devia-
tion. The parotid and submandibular ducts were all
patent. The CT scan of the face, neck, and chest
showed the mass on the tongue with no lymph node
involvement or other masses present. The TNM stag-
ing system identified the tumor as T2N0M0. Blood
electrolytes and CBC were all within normal limits.
There was no evidence of any opportunistic active
infections. There were no other lesions noted in the
oral cavity at the time of biopsy.
The patient underwent an incisional biopsy of
the mass in the left anterior tongue. The diagnosis
of the incisional biopsy was well-differentiated,
invasive, keratinizing squamous cell carcinoma
(Figs. 3 and 4). DNA extraction using the polymer-
ase chain reaction (PCR) showed only HPV type 32
to be present (Fig. 1).Case #2A 33-years old African–American male presented
to the Oral Surgery clinic at the Medical Center
complaining of pain while chewing due to a mass
on the tongue, which progressively increased in
size over a 7-months period (Fig. 5). The medical
history was significant for HIV and Hypertension.
The patient had a CD4 count of 246 and an un-
detectable viral load. The patient was presently
on ritonavir (Kaletra; Abbott Laboratories, IL,
USA), abacavir (Ziagen; Glaxosmithkline, Munich,
Germany) and efavirenz (Sustiva; Bristol Myers
Figure 1 Sequencing of DNA extraction using a multiplex PCR.
Figure 3 Low power photomicrograph showing mark-
edly hyperplastic surface epithelium with a hyperpara-
keratotic surface and superficial invasion into the lamina
propria.
Figure 2 Three cm indurated mass in anterior left
tongue with central ulceration.
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tobacco or illicit drug use or any family history
of cancer. Review of systems was unremarkable
with no otalgia, dysphagia, odynophagia, hoarse-
ness, or coughing. His physical examination was
unremarkable except for a 3 · 4 cm ulcerative,
indurated, and mass in the left ventral–lateral
region of the tongue (Fig. 5). Cranial nerves II–XII
were grossly intact, but the left side of the tongue
was mildly paresthetic. The tongue was adequately
fixed to the floor of the mouth with no abnormal
function. The parotid and submandibular ducts
were all patent with normal salivary flow. The CT
scan of the face, neck and chest showed the mass
on the tongue with no lymph node involvement or
other masses present. The stage of the tumor wasclassified as T2N0M0. No abnormality was detected
in the blood electrolytes. The patient also did not
exhibit any underlying opportunistic infections or
any active infections.
The patient underwent an incisional biopsy
under local anesthesia and the diagnosis was con-
sistent well-differentiated, invasive, keratinizing
squamous cell carcinoma (Figs. 6 and 7) DNA
extraction using the polymerase chain reaction
(PCR) showed only HPV type 32 to be present
(Fig. 1).
Figure 4 Higher power view of the same lesion seen in
Fig. 3 showing malignant cells easily recognizable as
being of squamous cell carcinoma.
Figure 6 Low power photomicrograph showing hyper-
parakeratotic surface and cords of poorly differentiated
epithelial cells streaming downward from the surface
epithelium.
Figure 7 High-power view of the same lesion seen in
Fig. 6 showing invading islands of malignant cells with
focal keratin formation recognizable as being squamous
cell carcinoma.
Figure 5 3 · 4 cm indurated mass on the left ventro-
lateral surface of the tongue extending to the floor of the
mouth.
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Oral squamous cell carcinoma (OSCC) is the most
common cancer of the oral cavity. Although use
of alcohol and tobacco are two known risk factors,
some evidence indicates that other factors, such as
infection with certain HPV subtypes and genetic
susceptibility, could also be involved in the carci-
nogenic process.15 HPV types 16 and 18 were de-
clared as human carcinogens by the International
Agency for Research on Cancer. They are the most
important single etiological agents of cervical
squamous cell carcinomas.16,17 However, their
relationship to OSCC is not well-defined. The high
prevalence of human papillomavirus (HPV) infec-
tions and associated morbidity among persons in-
fected with human immunodeficiency virus (HIV)
have only recently been recognized.
This increase in the occurrence of oral warts
may be significant because of the greater numbers
of HIV-positive individuals surviving longer due to
successful HAART therapy. Malignant transforma-
tion of cervical lesions or anal condylomas in HIV-
positive individuals could have significance for the
development of HPV-related oral cancers. Develop-
ment of HPV-associated malignancies occurs over
significant periods of time, and prior to the intro-
duction of HAART, many HIV-positive individuals
died of AIDS-related illnesses, but due to HAART
and the subsequent increased longevity of this pop-
ulation we may see an increase in HPV-related
pathology. Condylomas of the anus are commonly
considered as benign lesions,18 but oncogenic types
of HPV have been detected within anal carcinoma
cells, which raises the issue of the role that these
viruses may play in the progression of condyloma
to invasive carcinoma.19–21 HIV infection is thought
276 K. Shetty, J. Leighto increase the risk of anal carcinoma by 30 times.
In several studies, tonsillar and oropharyngeal car-
cinomas contained HPV DNA more commonly than
cancers at other head and neck sites.21,22
Preliminary analysis has identified HPV-32 as the
predominant genotype found in oral warts in the
New Orleans HIV+ cohort.23 Investigators think that
asymptomatic oral HPV infection occurs frequently
but that oral warts occur infrequently, presumably
due to immunological control of the virus. The crit-
ical aspects of the immune response that prevent
the progression from asymptomatic HPV infection
to HPV disease are unknown, but previous studies
have focused on HPV genotype-specific response
against the major capsid protein, L1. The increased
rate of HPV-related oral pathology seen in HIV-
positive patients highlights the need for a more
thorough understanding of the immune response
to oral HPV infections. This paper presents two
cases of HPV lesions associated with type 32, which
progressed to squamous sell carcinoma.References
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